🇺🇸 FDA
Patent

US 9592309

Positron emission tomography probe to monitor selected sugar metabolism in vivo

granted A61KA61K49/0433A61K51/0491

Quick answer

US patent 9592309 (Positron emission tomography probe to monitor selected sugar metabolism in vivo) held by The Regents of the University of California expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K49/0433, A61K51/0491